Página 14 - Mayores valores de U.S. Pharmaceuticals & Biotech por capitalización bursátil

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

ACTUALIZADO Jun 16, 2026

Descubra las empresas de gran capitalización U.S. Pharmaceuticals & Biotech que cotizan en NYSE y NASDAQ. Estas Pharmaceuticals & Biotech Companies están organizadas por capitalización bursátil.

712 empresas

Empresa	Último precio	7D Retorno	Rendimiento 1 año	Capitalización bursátil	Objetivo de los analistas	Valoración	Crecimiento	Div Rendimiento
BNTC	US$11.10	2.7%	-28.1%	US$389.2m	US$25.80	2.1	-27.3%	n/a
XFOR	US$4.04	4.9%	47.4%	US$384.8m	US$11.75	42.3	50.2%	n/a
LXEO	US$4.75	15.0%	12.0%	US$374.2m	US$20.90	1.6	49.3%	n/a
SNDL	US$1.43	-2.1%	11.7%	US$372.2m	US$4.27	0.5	138.4%	n/a
EDIT	US$2.36	-4.8%	0.4%	US$360.6m	US$5.78	9.4	-8.9%	n/a
PBYI	US$7.17	1.7%	109.0%	US$359.9m	US$5.00	15.0	-49.9%	n/a
RGNX	US$6.93	13.1%	-19.1%	US$358.3m	US$23.82	4.1	51.6%	n/a
STTK	US$4.33	1.4%	345.3%	US$355.0m	US$14.83	332.0	-24.4%	n/a
LRMR	US$3.40	-1.2%	24.1%	US$354.4m	US$15.11	2.2	53.5%	n/a
CMPX	US$1.97	2.6%	-17.2%	US$353.9m	US$8.82	1.9	57.2%	n/a
VNDA	US$5.73	-6.4%	27.6%	US$353.6m	US$14.13	1.6	62.4%	n/a
VSTM	US$4.01	5.0%	-24.5%	US$351.5m	US$16.00	7.1	51.3%	n/a
GLSI	US$23.88	8.0%	167.7%	US$351.0m	US$47.50	66.5	n/a	n/a
ZURA	US$3.52	-4.7%	208.3%	US$349.6m	US$15.67	1.5	-7.9%	n/a
AVIR	US$4.26	-3.0%	32.7%	US$340.9m	US$8.67	1.5	7.2%	n/a
CATX	US$2.93	-2.3%	-17.0%	US$335.3m	US$12.93	540.7	33.8%	n/a
ENTA	US$12.07	6.3%	71.2%	US$332.7m	US$20.14	5.1	23.9%	n/a
UPB	US$5.92	-11.5%	-42.6%	US$332.0m	US$38.25	97.0	-11.7%	n/a
SLN	US$6.71	11.6%	25.0%	US$330.6m	US$31.20	377.8	-27.3%	n/a
LAB	US$0.83	-5.6%	-23.7%	US$329.7m	US$1.55	3.8	-6.7%	n/a
CNXU	US$12.52	-3.8%	n/a	US$323.8m	n/a	46.3	n/a	n/a
ABEO	US$5.65	5.4%	-5.8%	US$322.0m	US$19.71	4.9	32.9%	n/a
AMRN	US$15.17	2.8%	13.8%	US$318.1m	US$12.50	1.5	76.0%	n/a
IRD	US$3.90	0.3%	318.8%	US$316.6m	US$10.47	26.5	54.4%	n/a

Page 14 of 30